Search results

As we all know, the rapid medical progress also requires constant further development in transfusion medicine, therefore, we are delighted to join the DGTI congress in Stuttgart to present our digital SaaS-system. Together with SATO Europe, we will demonstrate the seamless Vein-to-Vein solution. Welcome to Booth no 5. QTA Tracer System® is now the world’s First and Only MDR CE-marked Class IIa Temperature Monitoring Solution with Shelf-Life Management for Blood and Transfusion Medicine - uniquely developed for transfusion medicine. Welcome to schedule a demo. Email: fredrik.radenqrantz@tridentify.com QTA Tracer System® has successfully transitioned from the Medical Device Directive (MDD) to achieve formal MDR CE-marking as a Class IIa medical device under the European Union’s rigorous Medical Device Regulation (EU 2017/745). With this achievement, the QTA Tracer System® secures its position as the first and only temperature monitoring medical solution with shelf-life management worldwide to receive CE-marking according to MDR specifically indicated for transfusion medicine and blood products. Unmatched Innovation in Blood Safety and Cold Chain Logistics Unlike traditional data loggers, the QTA Tracer System® acts as an intelligent, real-time Internet of Medical Things (IoMT) solution. By applying custom biological profiles directly to individual blood bags, the system dynamically calculates the actual remaining shelf-life based on real-time exposure to temperature, light, and movement. This historic MDR CE-marking as a Class IIa guarantees that healthcare providers, blood banks, and laboratories can fully trust the system's automated quality decisions - safeguarding blood components from donor to patient, or "vein to vein".

We are delighted to join the annual BBTS conference in Glasgow 2026. QTA Tracer System® is now the world’s First and Only MDR CE-marked Class IIa Temperature Monitoring Solution with Shelf-Life Management for Blood and Transfusion Medicine. Please schedule a demo at our booth at BBTS as soon as possible. Email: ann-christine.jungmar@tridentify.com QTA Tracer System® has successfully transitioned from the Medical Device Directive (MDD) to achieve formal MDR CE-marking as a Class IIa medical device under the European Union’s rigorous Medical Device Regulation (EU 2017/745). With this achievement, the QTA Tracer System® secures its position as the first and only temperature monitoring medical solution with shelf-life management worldwide to receive CE-marking according to MDR specifically indicated for transfusion medicine and blood products. Unmatched Innovation in Blood Safety and Cold Chain Logistics Unlike traditional data loggers, the QTA Tracer System® acts as an intelligent, real-time Internet of Medical Things (IoMT) solution. By applying custom biological profiles directly to individual blood bags, the system dynamically calculates the actual remaining shelf-life based on real-time exposure to temperature, light, and movement. This historic MDR CE-marking as a Class IIa guarantees that healthcare providers, blood banks, and laboratories can fully trust the system's automated quality decisions - safeguarding blood components from donor to patient, or "vein to vein".

PRESS RELEASE July 24, 2026 Tridentify Achieves Historic Milestone: QTA Tracer System® Becomes World’s First and Only MDR CE-marked Class IIa Temperature Monitoring Solution with Shelf-Life Management for Blood and Transfusion Medicine Stockholm, SWEDEN — Tridentify, a pioneer in advanced health tech solutions, proudly announces that its patented QTA Tracer System® has successfully transitioned from the Medical Device Directive (MDD) to achieve formal MDR CE-marking as a Class IIa medical device under the European Union’s rigorous Medical Device Regulation (EU 2017/745). With this achievement, the QTA Tracer System® secures its position as the first and only temperature monitoring medical solution with shelf-life management worldwide to receive CE-marking according to MDR specifically indicated for transfusion medicine and blood products. Unmatched Innovation in Blood Safety and Cold Chain Logistics Unlike traditional data loggers, the QTA Tracer System® acts as an intelligent, real-time Internet of Medical Things (IoMT) solution. By applying custom biological profiles directly to individual blood bags, the system dynamically calculates the actual remaining shelf-life based on real-time exposure to temperature, light, and movement. This historic MDR CE-marking as a Class IIa guarantees that healthcare providers, blood banks, and laboratories can fully trust the system's automated quality decisions - safeguarding blood components from donor to patient, or "vein to vein". Regulatory Excellence Ahead of the SoHO Mandate The transition from MDD to MDR CE-marking demonstrates the robustness of Tridentify's clinical evidence, cybersecurity, and stringent quality management. This breakthrough aligns perfectly with the upcoming EU Substances of Human Origin (SoHO) Regulation, that will come into effect in August 2027, establishing Tridentify as the definitive global standard for audit-readiness and compliance. "Achieving MDR CE-marking as a Class IIa medical device is an incredible validation of our team's vision to eliminate cold chain uncertainties entirely," said Ann-Christine Jungmar, CEO, at Tridentify. "Being the world's only MDR CE-marked Class IIa temperature monitoring solution with shelf-life management for transfusion medicine allows us to uniquely empower hospitals to minimize blood waste, drastically reduce costs, and, most importantly, maximize patient safety", Ann-Christine continues. Key Benefits of the MDR CE-marked QTA Tracer System®: Dynamic Shelf-Life Management: Automatically calculates the remaining shelf-life and continuously displays the status. The evidence-based display eliminates uncertainties. (Green=OK to use. Red=Not OK). Waste Reduction: Safely recover blood bags and reduce waste. Traceability: Cloud-based data tracking that meets absolute traceability and compliance requirements. About Tridentify ABTridentify is a Swedish medical technology company dedicated to "Safeguarding Medicines for Life®". Through its proprietary SaaS platform and intelligent QTA Tracers, Tridentify delivers real-time quality control and traceability for temperature-sensitive blood products, biologicals, and pharmaceuticals globally by "Safeguarding as Service®". Media Contact:Ann-Christine Jungmar, CEO Mobile: +46 (0) 708 71 46 76 ann-christine.jungmar@tridentify.comwww.tridentify.com

We are delighted to announce that together with SATO, Tridentify will present the world's first Vein-to-Vein Traceability with shelf-life management, at ISBT in Kuala Lumpur on June 20-24. Both Ann-Christine and Fredrik from Tridentify will be present and may accommodate 1-on-1 sessions and individual meetings to further discuss the innovative monitoring of temperature sensitive blood products and shelf-life management at the International Society of Blood Transfusion (ISBT) Congress in Malaysia. Book a meeting or simply pop-by SATOs Booth at E17, Level GF, Hall 5, Kuala Lumpur Convention Centre to discover how SATO’s PJM RFID technology and Tridentify's QTA Tracer System® enable secure vein-to-vein traceability and shelf-life management across the entire blood supply chain, improving efficiency, reliability, and patient safety - from "Vein-to-Vein".

Tridentify is proud to announce a new distribution agreement with ADYTON, a leading commercialization partner for advanced healthcare technologies in Central Europe. Through this partnership, the QTA Tracer System® and its Shelf-Life Management feature, will be introduced further into the transfusion medicine market across Poland, Czechia, and Slovakia, strengthen Tridentify’s presence in the region and expand access to safer and more efficient blood product management solutions. Tridentify is the only European known Medtech Company with a MDD class IIa device with shelf-life management. MDR in 2026. Please read the pressrelease attached.

We are excited to announce that Tridentify will participate in the ISBT 2026 Congress, taking place in Kuala Lumpur, Malaysia, from 20–24 June 2026. ISBT is one of the world’s leading events for professionals in transfusion medicine, blood management, cellular therapies, and related healthcare technologies. The congress brings together experts, innovators, researchers, and healthcare organizations from across the globe to share knowledge, explore new technologies, and discuss the future of blood and transfusion safety. For Tridentify, ISBT represents an important opportunity to connect with partners, healthcare professionals, blood centers, and industry leaders who share our commitment to improving traceability, safety, and efficiency in healthcare. . Let’s Meet in Kuala Lumpur During the congress, the Tridentify team will be available for meetings and discussions about: Shelf-Life Management matters Digital traceability solutions for healthcare and transfusion workflows Enhanced operational efficiency and eliminate uncertainty Improving patient safety through reliable shelf-life management systems Integration opportunities with existing healthcare infrastructure Improving patient safety through reliable shelf-life management systems Secure product identification throughout the supply chain Future innovations in blood management and medical product traceability Whether you are already familiar with Tridentify or would like to learn more about our solutions, we would be delighted to meet you during ISBT 2026. Schedule a Meeting with Us If you are attending ISBT 2026 and would like to meet with the Tridentify team, we encourage you to contact us in advance to schedule a meeting. We look forward to discussing how Tridentify’s evidence based Shelf-Life management solution can support your organization and contribute to safer, smarter healthcare processes. 📩 Contact us email: fredrik.radencrantz@tridentify.com or ann-christine.jungmar@tridentify.com

QTA Tracer System ®   - contact to get a live demonstration of the unique shelf-life management temperature monitoring solution Patient Blood Management (PBM) has become a critical focus in healthcare, aiming to improve patient outcomes by optimizing the use of blood and blood products. The NATA26 annual symposium, brings together a diverse group of healthcare professionals, including haematologists, transfusion medicine specialists, anaesthesiologists, intensive care and emergency physicians, surgeons, perfusionists, nurses, and biomedical scientists. This gathering fosters collaboration across academic, clinical, and industry sectors, all united by a shared interest in PBM, haemostasis, and thrombosis. Tridentify will be there, and will demonstrate the shelf-life management system and the value of technology and data in supporting PBM initiatives. Our solution help healthcare providers monitor the shelf-life of blood components during storage, transport and distribution including support any healthcare professional at the blood bank or before transfusion. For a demonstration in Spain ; e-mail Fredrik Radencrantz fredrik.radencrantz@tridentify.com or ann-christine.jungmar@tridentify.com Demonstration can be scheduled via digital presentation if you are not going to the Symposium. www.tridentify.com

Meet Tridentify’s Senior Advisor, Mr. Dirk Op de Beeck , at WHX (formerly Arab Health) in Dubai. Dirk is available on WhatsApp/Mobile number + 32 47 989 18 14.   "Tridentify, a Swedish MedTech/SaaS company, offers an easy-to-use, patented cold chain monitoring solution for temperature sensitive blood products, pharmaceuticals, vaccines and more. QTA Tracer System® is a real-time temperature monitoring solution that eliminates the uncertainty of temperature sensitive products throughout the cold chain."

Meet us in Vienna! Nov 3 - 5, 2025 Looking for a reliable, high-precision temperature monitoring solution for pharmaceutical deliveries, clinical trials, assets or any other temperature-sensitive products? Meet us in Vienna! Contact Fredrik Radencrantz: Email:   Fredrik.radencrantz@tridentify.com SMS:  +46 73 834 11 88 Or schedule a meeting via the partneringONE  tool. Tridentify provides a state-of-the-art cold chain monitoring and shelf-life management system (based on stability data) that ensures safe and reliable deliveries. Our device gives a clear green or red signal upon arrival, enabling automatic release decisions without manual intervention. About Tridentify We are a Swedish Medtech company offering an advanced SaaS solution powered by IoT/IoTM devices designed for a wide range of temperature-sensitive pharmaceuticals and biological products. One device covers a temperature range of –40°C to +70°C Our patented shelf-life calculation, based on specific stability data, monitors the actual usability of each unit throughout storage and transport. Deviation reporting is included for all deliveries – even those deemed acceptable. Our system provides: Automatic release of individual items or boxes Full traceability and quality assurance Improved workflows and patient safety ISO 9001 & ISO 13485 Medical Device class IIa Compliance with regulatory requirements, including the upcoming SoHO (Substances of Human Origin) regulations effective in 2027

Tridentify will be joining the NLS Days to present: QTA Tracer System® - Safeguarding as a Service® Eliminate uncertainties , avoid discarding expensive APIs/pharma products, and ensure handling, storage, transportation, and deliveries to the end destination according to protocol. Benefit from alarm notifications that are sent when defined temperature thresholds are met. ​ Tridentify provides Pharmaceutical companies, CROs, CDMOs, Bio Tech and Life Science companies with a clever, patented solution designed to deliver an easy-to-use, end-to-end, real-time data, when applying the unique temperature monitoring solution during storing, handling and transporting temperature sensitive clinical trial materials. ​ ​ QTA Tracer System® is a cost-effective and efficient insurance to eliminate costly, compromised clinical trials due to variables such as fluctuating temperatures, light or movements. ​ ​​​​​​ QTA Tracer System® - cold chain logistics monitoring for Life Science companies   Maintain Quality, Traceability, Accessibility and Audit readiness Prevent/reduce waste Reduce manual errors and work Effortless data sharing  Save time and money Send an e-mail to Ann-Christine.jungmar@tridentify.com or invite for a meeting via the PartneringOne tool.

Looking forward to network and discuss, and get a deeper understanding of the UN's needs and challenges, as well as presenting QTA Tracer System ® - shelf-life management SaaS solution to the UN-Systems and others. I, Ann-Christine Jungmar, am excited to join the Nordic Procurement Seminar, taking place June 10-11 2025 in Copenhagen . The seminar is a unique meeting point for Nordic companies across industries and sectors, providing an opportunity to engage directly with UN officers working with procurement. The seminar will be held in the UN city in Copenhagen and is hosted by Denmark, Norway, Sweden, Iceland, and Finland, along with Danish Industry, Innovation Norway, Business Sweden, Business Iceland, and Business Finland. The seminar offers companies valuable insights into the workings of UN procurement. Participants will have the chance to meet procurement officers and UN buyers from a wide range of UN agencies. The UN representatives will deliver presentations and take part in workshops sharing knowledge on conducting businesses with the UN and provide know-how on how to become an attractive supplier. During the two-day seminar, a variety of topics will be covered, including energy, life sciences, management, infrastructure, and logistics.

Tridentify has signed a non-exclusive distribution agreement with ATN Medical in Portugal. ATN Medical is a well-established distributor in Portugal and represents several respected brands within the healthcare industry. The QTA Tracer System® enables ATN Medical to expand into transfusion medicine with a special emphasis on blood banks, blood products and transfusion medicine in Portugal. ATN Medical has a well-established network of sales representatives, clinicians, KOLs and customers in Portugal. The sales activities will start immediately. ”ATN Medical is expanding and is a growing company. ATN Medical is committed and engaged, and has established operations throughout Portugal, from which we will benefit from the first day”. We are excited about the partnership and look forward to close collaboration, says Ann-Christine Jungmar, CEO at Tridentify. “The unique QTA Tracer System® enables us to expand into transfusion medicine in Portugal. We will benefit from our well-established network and experience of targeting hospitals and the OR, as well as other departments where the need of blood is high.“ “We are a dynamic and innovative company that offers customized solutions that optimize the effectiveness of the healthcare professionals and improve the clinical outcome for patients. Tridentify’s SaaS solution fits perfectly into our strategy of expanding our market share within the area of transfusion medicine in Portugal.” “The ease-of-use, the fact that the QTA tracers eliminate cold chain uncertainties during handling, storing, and transporting blood products and save lives, are three important factors that make this a compelling opportunity for ATN Medical. We are looking forward to a successful partnership”, Nuno Carvalho, General Manager at ATN Medical Lda., says. Tridentify develops, manufactures, markets and sells the QTA Tracer System®,  a unique patented system for automatic Shelf-Life management, across the world. The system safeguards cold chain logistics with real-time tracking of temperature, light and movement of sensitive medicines, vaccines, blood, plasma, stem cells, biologicals, pharmaceuticals and more. The combination of the CE-marked and patented system with easy-to-use tracers, shelf-life management and innovative user interface adds value to the healthcare industry by eliminating cold chain uncertainties and enables automatic release. The main benefits of the QTA Tracer System®, it: - Eliminates uncertainty - Increases patient safety - Streamlines cold chain processes - Reduces waste - Saves time and money Shelf-Life Management, based on stability budget of any biologics or pharma product— Safeguarding as a Service®